{"id":"https://openalex.org/W4407893765","doi":"https://doi.org/10.1016/j.plefa.2025.102671","title":"The single-dose kinetics of [1\u201314C]-labelled EPA and DHA, administered to male rats as TAG, phosphatidylcholine (PC), and lyso-phosphatidylcholine (LPC), is structurally similar across lipid forms and can be described using the same compartmental models","display_name":"The single-dose kinetics of [1\u201314C]-labelled EPA and DHA, administered to male rats as TAG, phosphatidylcholine (PC), and lyso-phosphatidylcholine (LPC), is structurally similar across lipid forms and can be described using the same compartmental models","publication_year":2025,"publication_date":"2025-02-25","ids":{"openalex":"https://openalex.org/W4407893765","doi":"https://doi.org/10.1016/j.plefa.2025.102671","pmid":"https://pubmed.ncbi.nlm.nih.gov/40107183"},"language":"en","primary_location":{"id":"doi:10.1016/j.plefa.2025.102671","doi":"https://doi.org/10.1016/j.plefa.2025.102671","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.plefa.2025.102671","pdf_url":"https://www.plefa.com/article/S0952-3278(25)00008-0/pdf","source":{"id":"https://openalex.org/S9307485","display_name":"Prostaglandins Leukotrienes and Essential Fatty Acids","issn_l":"0952-3278","issn":["0952-3278","1532-2823"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prostaglandins, Leukotrienes and Essential Fatty Acids","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.plefa.com/article/S0952-3278(25)00008-0/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026241154","display_name":"Nils Hoem","orcid":"https://orcid.org/0000-0002-3124-8290","observed_orcids":["https://orcid.org/0000-0002-3124-8290"]},"institutions":[{"id":"https://openalex.org/I4210095065","display_name":"Aker (Norway)","ror":"https://ror.org/00p64v472","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210095065"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Nils Hoem","raw_affiliation_strings":["Aker BioMarine Human Ingredients AS, Lysaker Norway. Electronic address: nils.hoem@akerbiomarine.com"],"raw_orcid":"https://orcid.org/0000-0002-3124-8290","affiliations":[{"raw_affiliation_string":"Aker BioMarine Human Ingredients AS, Lysaker Norway. Electronic address: nils.hoem@akerbiomarine.com","institution_ids":["https://openalex.org/I4210095065"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stephen Harris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102587","display_name":"Pharmaron (United Kingdom)","ror":"https://ror.org/01fn7y155","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210102587","https://openalex.org/I4405279148"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Harris","raw_affiliation_strings":["Department of Drug Metabolism, Pharmaron, Pegasus Way, Rushden NN10 6ER, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Pharmaron, Pegasus Way, Rushden NN10 6ER, UK","institution_ids":["https://openalex.org/I4210102587"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Grace Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102587","display_name":"Pharmaron (United Kingdom)","ror":"https://ror.org/01fn7y155","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210102587","https://openalex.org/I4405279148"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Grace Scott","raw_affiliation_strings":["Department of Drug Metabolism, Pharmaron, Pegasus Way, Rushden NN10 6ER, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Pharmaron, Pegasus Way, Rushden NN10 6ER, UK","institution_ids":["https://openalex.org/I4210102587"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005722766","display_name":"Petter\u2010Arnt Hals","orcid":"https://orcid.org/0000-0003-4542-1290","observed_orcids":["https://orcid.org/0000-0003-4542-1290"]},"institutions":[{"id":"https://openalex.org/I4210095065","display_name":"Aker (Norway)","ror":"https://ror.org/00p64v472","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210095065"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Petter-Arnt Hals","raw_affiliation_strings":["Aker BioMarine Human Ingredients AS, Lysaker Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aker BioMarine Human Ingredients AS, Lysaker Norway","institution_ids":["https://openalex.org/I4210095065"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5026241154"],"corresponding_institution_ids":["https://openalex.org/I4210095065"],"apc_list":{"value":3790,"currency":"USD","value_usd":3790},"apc_paid":{"value":3790,"currency":"USD","value_usd":3790},"fwci":1.6227,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.7873909,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"205","issue":null,"first_page":"102671","last_page":"102671"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11844","display_name":"Lipid metabolism and biosynthesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10450","display_name":"Aquaculture Nutrition and Growth","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1104","display_name":"Aquatic Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eicosapentaenoic-acid","display_name":"eicosapentaenoic acid","score":0.9900000095367432},{"id":"https://openalex.org/keywords/docosahexaenoic-acid","display_name":"docosahexaenoic acid","score":1.0},{"id":"https://openalex.org/keywords/docosapentaenoic-acid","display_name":"docosapentaenoic acid","score":0.9869999885559082},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7319999933242798},{"id":"https://openalex.org/keywords/phosphatidylcholine","display_name":"phosphatidylcholine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lysophosphatidylcholine","display_name":"lysophosphatidylcholine","score":0.9760000109672546},{"id":"https://openalex.org/keywords/compartmental-modeling","display_name":"compartmental modeling","score":0.7749999761581421},{"id":"https://openalex.org/keywords/first-order-elimination","display_name":"first-order elimination","score":0.5669999718666077},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.4099999964237213},{"id":"https://openalex.org/keywords/fecal-excretion","display_name":"fecal excretion","score":0.5630000233650208},{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C2776330855","wikidata":"https://www.wikidata.org/wiki/Q650187","display_name":"Phosphatidylcholine","level":4,"score":0.9264574646949768},{"id":"https://openalex.org/C148898269","wikidata":"https://www.wikidata.org/wiki/Q1108792","display_name":"Kinetics","level":2,"score":0.6949928402900696},{"id":"https://openalex.org/C2780330291","wikidata":"https://www.wikidata.org/wiki/Q6710262","display_name":"Lyso-","level":4,"score":0.6362460851669312},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6011168956756592},{"id":"https://openalex.org/C2776648337","wikidata":"https://www.wikidata.org/wiki/Q7187403","display_name":"Phos","level":2,"score":0.5169922113418579},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.4881609082221985},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.40901052951812744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3507060408592224},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3386901021003723},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3354779779911041},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21077758073806763},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18800321221351624},{"id":"https://openalex.org/C161694136","wikidata":"https://www.wikidata.org/wiki/Q910990","display_name":"Scintillator","level":3,"score":0.0},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C119599485","wikidata":"https://www.wikidata.org/wiki/Q43035","display_name":"Electrical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C94915269","wikidata":"https://www.wikidata.org/wiki/Q1834857","display_name":"Detector","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000097922","descriptor_name":"Liquid Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004281","descriptor_name":"Docosahexaenoic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004281","descriptor_name":"Docosahexaenoic Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008244","descriptor_name":"Lysophosphatidylcholines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008244","descriptor_name":"Lysophosphatidylcholines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010713","descriptor_name":"Phosphatidylcholines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010713","descriptor_name":"Phosphatidylcholines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011849","descriptor_name":"Radioactive Tracers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.plefa.2025.102671","doi":"https://doi.org/10.1016/j.plefa.2025.102671","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.plefa.2025.102671","pdf_url":"https://www.plefa.com/article/S0952-3278(25)00008-0/pdf","source":{"id":"https://openalex.org/S9307485","display_name":"Prostaglandins Leukotrienes and Essential Fatty Acids","issn_l":"0952-3278","issn":["0952-3278","1532-2823"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prostaglandins, Leukotrienes and Essential Fatty Acids","raw_type":"journal-article"},{"id":"pmid:40107183","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40107183","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prostaglandins, leukotrienes, and essential fatty acids","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.plefa.2025.102671","doi":"https://doi.org/10.1016/j.plefa.2025.102671","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.plefa.2025.102671","pdf_url":"https://www.plefa.com/article/S0952-3278(25)00008-0/pdf","source":{"id":"https://openalex.org/S9307485","display_name":"Prostaglandins Leukotrienes and Essential Fatty Acids","issn_l":"0952-3278","issn":["0952-3278","1532-2823"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prostaglandins, Leukotrienes and Essential Fatty Acids","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4407893765.pdf","grobid_xml":"https://content.openalex.org/works/W4407893765.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W1611593531","https://openalex.org/W1653281013","https://openalex.org/W1696896561","https://openalex.org/W1791771324","https://openalex.org/W1852583464","https://openalex.org/W1918531874","https://openalex.org/W1969788841","https://openalex.org/W1971091197","https://openalex.org/W1972017016","https://openalex.org/W1987517033","https://openalex.org/W1998969796","https://openalex.org/W2000248987","https://openalex.org/W2008292459","https://openalex.org/W2010954893","https://openalex.org/W2017671361","https://openalex.org/W2025347047","https://openalex.org/W2035084975","https://openalex.org/W2037231636","https://openalex.org/W2038831823","https://openalex.org/W2062908470","https://openalex.org/W2064358352","https://openalex.org/W2069729224","https://openalex.org/W2075007679","https://openalex.org/W2081721763","https://openalex.org/W2092474731","https://openalex.org/W2098825532","https://openalex.org/W2101513524","https://openalex.org/W2104285446","https://openalex.org/W2109225320","https://openalex.org/W2111143090","https://openalex.org/W2113838437","https://openalex.org/W2125262225","https://openalex.org/W2127030148","https://openalex.org/W2127402545","https://openalex.org/W2131094572","https://openalex.org/W2131133480","https://openalex.org/W2133983235","https://openalex.org/W2135763607","https://openalex.org/W2140531245","https://openalex.org/W2141826274","https://openalex.org/W2183659943","https://openalex.org/W2194277806","https://openalex.org/W2317225560","https://openalex.org/W2344912771","https://openalex.org/W2411815569","https://openalex.org/W2517076553","https://openalex.org/W2518918308","https://openalex.org/W2571767161","https://openalex.org/W2573213128","https://openalex.org/W3016743665","https://openalex.org/W3036467634","https://openalex.org/W4253093206","https://openalex.org/W6638413812","https://openalex.org/W6678959743","https://openalex.org/W6781226502"],"related_works":["https://openalex.org/W2099693904","https://openalex.org/W2023179128","https://openalex.org/W2151182989","https://openalex.org/W2075359481","https://openalex.org/W2141826274","https://openalex.org/W1969570572","https://openalex.org/W2885760508","https://openalex.org/W2985985977","https://openalex.org/W2083901632","https://openalex.org/W2044583051"],"abstract_inverted_index":{"C]-radiolabelled":[0],"EPA":[1,79,185],"and":[2,20,39,50,88,117,127,139,145,164,186,207,217,230,233,246],"DHA":[3,75,247],"as":[4,192,239,241],"triglycerides":[5],"(TAG),":[6],"phosphatidylcholine":[7],"(PC),":[8],"or":[9,195],"lyso-phosphatidylcholine":[10],"(LPC)":[11],"by":[12,150],"gavage.":[13],"LPC":[14,111],"was":[15,41,69,208],"also":[16],"administered":[17,191],"intravenously.":[18],"Plasma":[19],"whole":[21],"blood":[22,144],"concentration-time":[23],"profiles":[24],"were":[25,141],"recorded":[26,42],"from":[27,115,160],"0":[28],"to":[29,45,92,153,202,211,227,235],"168":[30],"hours,":[31],"while":[32],"cumulative":[33],"radioactivity":[34,134,156],"in":[35,70,119,136,248],"expired":[36,137],"air,":[37],"faeces,":[38],"urine":[40],"for":[43,58,183],"up":[44],"336":[46],"hours.":[47],"Non-compartmental":[48],"analysis":[49],"compartmental":[51,177],"modelling":[52],"demonstrated":[53],"overall":[54],"first-order":[55,161],"radiotracer":[56],"kinetics":[57],"both":[59,228],"fatty":[60],"acids,":[61],"with":[62,143],"comparable":[63],"terminal":[64],"half-lives.":[65],"The":[66,176,197],"primary":[67],"difference":[68],"maximum":[71,93],"concentration":[72,94],"(Cmax":[73],"((\u00b5g-eq/g)/(mg/kg)):":[74],"=":[76,80,99,104,109],"0.18\u00b1":[77],"0.089,":[78],"0.24\u00b1":[81],"0.103;":[82],"P":[83,108],"<":[84],"0.0001).":[85],"Between":[86],"TAG":[87,103,116,163],"PC,":[89,165,194],"only":[90],"time":[91],"(Tmax":[95],"(h))":[96],"differed":[97],"(PC":[98],"3.23":[100],"\u00b1":[101,106],"0.94,":[102],"2.55":[105],"0.77;":[107],"0.0004).":[110],"showed":[112],"significant":[113],"differences":[114],"PC":[118],"area":[120],"under":[121],"the":[122],"curve":[123],"(AUC0-inf),":[124],"Cmax,":[125],"Tmax,":[126],"total":[128],"clearance":[129],"(CL/F":[130],"(mL/(kg":[131],"h))).":[132],"Cumulative":[133],"levels":[135],"air":[138],"faeces":[140],"consistent":[142],"plasma":[146],"kinetics.":[147],"As":[148],"suggested":[149],"early-phase":[151],"(0":[152],"48":[154],"hours)":[155],"accumulation,":[157],"which":[158],"deviated":[159],"behaviour,":[162],"but":[166],"not":[167],"LPC,":[168],"exhibited":[169],"some":[170],"faecal":[171],"loss":[172],"without":[173],"systemic":[174],"absorption.":[175],"models":[178,223],"developed":[179],"performed":[180],"equally":[181],"well":[182,240],"radiolabelled":[184],"DHA,":[187,218],"regardless":[188],"of":[189,243],"whether":[190],"TAG,":[193],"LPC.":[196],"model":[198],"can":[199,224],"be":[200,225],"adapted":[201,234],"handle":[203],"non-zero":[204],"endogenous":[205],"baselines":[206],"successfully":[209],"applied":[210,226],"non-radiolabelled":[212],"EPA,":[213,244],"docosapentaenoic":[214],"acid":[215],"(DPA),":[216],"quantified":[219],"via":[220],"LC-MS/MS.":[221],"These":[222],"radioactive":[229],"stable":[231],"isotopes":[232],"include":[236],"organ-specific":[237],"kinetics,":[238],"those":[242],"DPA,":[245],"other":[249],"species,":[250],"including":[251],"humans.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-02-25T00:00:00"}